B
Bullisch
Bullisch · 25%SXTC
$2.24
Szenariopreis
$3.200
-0.316 (-9.86%)Zum Schluss
Loading chart…
- Hoch
- 3.538
- Eröffnung
- 3.350
- Volumengewichteter Durchschnittskurs
- 3.27
- Volumen
- 108.67K
- Marktkap.
- 1.01M
- Tief
- 3.070
- Umsatz
- 355.27K
- EV/EBITDA, TTM
- 0.00
China SXT Pharmaceuticals Inc is a holding company mainly engaged in the research, development, manufacture, marketing and sales of Chinese traditional medicine products (TCMP). The Company sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The Company sells its products under the brand Suxuantang.
KI-Analyse of China SXT Pharmaceuticals Inc (SXTC)
VerkaufenGiven the current price of $0.04, a staggering 100% year-to-date change, and an RSI of 28.41 indicating oversold conditions, this asset is not a good buy right now. The stock has experienced a 98.40% decline over the last 20 days, reflecting severe market distress and lack of investor confidence. The main risk is the company's negative earnings with a P/E ratio of -0.0534, indicating ongoing losses.
Bewertungskennzahlen
Das aktuelle erwartete KGV von China SXT Pharmaceuticals Inc (SXTC) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von 0.00.
Alphio-AI-Kursszenarien für SXTC
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.
Event-Zeitleiste
News
8.510-09NewsfilterChina SXT Pharmaceuticals Closes $12 Million Direct Offering
8.510-08PRnewswireChina SXT Pharmaceuticals Announces Direct Offering of 8 Million Shares
- 8.507-24Newsfilter
China SXT Pharmaceuticals Closes $9 Million Direct Offering
8.507-23seekingalphaChina SXT Pharmaceuticals Secures $9M Direct Offering
9.502-02BenzingaDarkIris Inc Reports 27.3% Revenue Growth, Shares Surge
SXTC FAQ – beantwortet von Alphio AI
China SXT Pharmaceuticals Inc is a holding company mainly engaged in the research, development, manufacture, marketing and sales of Chinese traditional medicine products (TCMP). The Company sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The Company sells its products under the brand Suxuantang. It operates in the Healthcare sector (PHARMACEUTICAL PREPARATIONS industry).
Given the current price of $0.04, a staggering 100% year-to-date change, and an RSI of 28.41 indicating oversold conditions, this asset is not a good buy right now. The stock has experienced a 98.40% decline over the last 20 days, reflecting severe market distress and lack of investor confidence. The main risk is the company's negative earnings with a P/E ratio of -0.0534, indicating ongoing losses.
Community
Mehr ↗
$GNPX October 2024 and October 2025. Two Octobers in a row produced strong rallies, and anyone who has followed GNPX closely would recognize that. In 2024 the month finished up about 522%...... The sample is two years, both moves were tied to a thin float, and the current float is even smaller than it was over the last two years, so it may be worth watching for a trade. For that reason, I mentioned GNPX as a potential $SXTC type mover. Let's see what this month brings.
Mehr anzeigen
The only micro float bio name similar to $SXTC, which rose over 500% today, is $GNPX, with just a 480K free float and also a cash-rich company with a net cash per share of $15 per DT.
Mehr anzeigen
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.